---
title: "Post-pandemic shifts in respiratory pathogen circulation: Six-year FilmArray® surveillance in Toky"
id: "medrxiv-18-post-pandemic-ecological-reshaping-of-respiratory-pathogen-circulation-a-six"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-18-post-pandemic-ecological-reshaping-of-respiratory-pathogen-circulation-a-six"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.28.26360747v1?rss=1"
published_at: "2026-09-02T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Post-pandemic shifts in respiratory pathogen circulation: Six-year FilmArray® surveillance in Toky
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-18-post-pandemic-ecological-reshaping-of-respiratory-pathogen-circulation-a-six
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.28.26360747v1?rss=1)
- **Published At:** 2026-09-02T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This study analyzed 19,968 respiratory samples tested with the **BioFire® FilmArray® Respiratory Panel** at a Tokyo hospital from January 2020 to March 2026. - At least one respiratory pathogen was detected in 27.8% of tests; co-detection occurred in 14.0% of positive specimens. - Pathogen resurgence after relaxation of COVID-19 measures was asynchronous and **pathogen-specific**: influenza stayed suppressed until late 2022 then re-emerged in large seasonal epidemics, while RSV, human metapneumovirus, and Mycoplasma pneumoniae showed distinct rebound patterns. - Age-related differences were observed: **human rhinovirus/enterovirus** predominated in young children, whereas **SARS-CoV-2** predominated in older adults. - Pairwise pathogen association analyses revealed both positive and negative relationships; these associations varied by age group and study period. - The authors conclude that respiratory pathogen ecology changed substantially across the transition from pandemic to post-pandemic periods, and they recommend continued surveillance to inform infection control strategies. - The study is a preprint (not peer reviewed). Ethical approval was obtained from the Japan Institute for Health Security (NCGM-004190). Data are available from corresponding authors on request. - Funding was provided by the NCGM Collaborative Research Fund (Grant Number 22K900C).
## Clinical Analysis & Structured Key Points
Post-pandemic ecological reshaping of respiratory pathogen circulation: A six-year FilmArray®-based surveillance study in Tokyo, Japan (2020-2026) | medRxiv Skip to main content Post-pandemic ecological reshaping of respiratory pathogen circulation: A six-year FilmArray®-based surveillance study in Tokyo, Japan (2020-2026) Junko S Takeuchi , Masami Kurokawa , Kei Yamamoto , Junko Yamanaka , Eriko Morino , Sakino Takayanagi-Nishisako , Norio Ohmagari , Wataru Sugiura , Moto Kimura doi: https://doi.org/10.64898/2026.08.28.26360747 Junko S Takeuchi 1 Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, Japan Institute for Health Security, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: takeuchi.j{at}jihs.go.jp Masami Kurokawa 2 Department of Laboratory Testing, National Center for Global Health and Medicine, Japan Institute for Health Security, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kei Yamamoto 3 Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Junko Yamanaka 4 Department of Pediatrics, National Center for Global Health and Medicine, Japan Institute for Health Security, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Eriko Morino 5 Department of Respiratory Medicine, National Center for Global Health and Medicine, Japan Institute for Health Security, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sakino Takayanagi-Nishisako 1 Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, Japan Institute for Health Security, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Norio Ohmagari 3 Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Wataru Sugiura 6 6Center for Clinical Sciences, Japan Institute for Health Security, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan Find this author on Google Scholar Find this author on PubMed Search for this author on this site Moto Kimura 1 Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, Japan Institute for Health Security, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background The COVID-19 pandemic substantially altered respiratory pathogen circulation worldwide. However, longitudinal analyses of changes in respiratory pathogen ecology across the pandemic and post-pandemic periods remain limited. Methods We analyzed 19,968 respiratory samples tested with the BioFire® FilmArray® Respiratory Panel at a hospital in Tokyo, Japan, between January 2020 and March 2026. We evaluated temporal changes in pathogen circulation, age-specific epidemiology, co-detection patterns, pairwise pathogen associations, and clinical parameters. Results At least one respiratory pathogen was detected in 27.8% of tests. Respiratory pathogens resurged asynchronously following the relaxation of COVID-19-related public health measures. Influenza virus circulation remained markedly suppressed until late 2022 before re-emerging in successive large seasonal epidemics, whereas other pathogens, including RSV, human metapneumovirus, and Mycoplasma pneumoniae, exhibited distinct resurgence patterns. Pathogen distributions also varied by age. Human rhinovirus/enterovirus remained predominant among young children, whereas SARS-CoV-2 predominated among older adults. Co-detection occurred in 14.0% of positive specimens and was significantly more frequent in younger patients. Pairwise analysis identified both positive and negative pathogen associations; however, the patterns varied across age groups and study periods. Conclusions Respiratory pathogen circulation changed substantially during the transition from the COVID-19 pandemic to the post-pandemic period, with pathogen-specific, age- and period-dependent patterns. Continued surveillance is warranted to determine how respiratory pathogen circulation will evolve and to inform infection control strategies in the post-pandemic era. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was approved by the Ethics Review Committee of the Japan Institute for Health Security (JIHS), Japan (NCGM-004190). All methods were performed in accordance with relevant guidelines and regulations. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The data that support the findings of this study, excluding those subjects to privacy or ethical restrictions, are available from the corresponding authors upon reasonable request. Funder Information Declared the NCGM Collaborative Research Fund , Grant Number 22K900C Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted September 02, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Post-pandemic ecological reshaping of respiratory pathogen circulation: A six-year FilmArray®-based surveillance study in Tokyo, Japan (2020-2026) Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Post-pandemic ecological reshaping of respiratory pathogen circulation: A six-year FilmArray®-based surveillance study in Tokyo, Japan (2020-2026) Junko S Takeuchi , Masami Kurokawa , Kei Yamamoto , Junko Yamanaka , Eriko Morino , Sakino Takayanagi-Nishisako , Norio Ohmagari , Wataru Sugiura , Moto Kimura medRxiv 2026.08.28.26360747; doi: https://doi.org/10.64898/2026.08.28.26360747 Share This Article: Copy Citation Tools Post-pandemic ecological reshaping of respiratory pathogen circulation: A six-year FilmArray®-based surveillance study in Tokyo, Japan (2020-2026) Junko S Takeuchi , Masami Kurokawa , Kei Yamamoto , Junko Yamanaka , Eriko Morino , Sakino Takayanagi-Nishisako , Norio Ohmagari , Wataru Sugiura , Moto Kimura medRxiv 2026.08.28.26360747; doi: https://doi.org/10.64898/2026.08.28.26360747 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (614) Allergy and Immunology (896) Anesthesia (326) Cardiovascular Medicine (4769) Dentistry and Oral Medicine (474) Dermatology (407) Emergency Medicine (643) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1614) Epidemiology (15834) Forensic Medicine (32) Gastroenterology (1194) Genetic and Genomic Medicine (6983) Geriatric Medicine (727) Health Economics (1057) Health Informatics (4982) Health Policy (1426) Health Systems and Quality Improvement (1736) Hematology (581) HIV/AIDS (1335) Infectious Diseases (except HIV/AIDS) (16243) Intensive Care and Critical Care Medicine (1161) Medical Education (663) Medical Ethics (151) Nephrology (720) Neurology (7193) Nursing (363) Nutrition (1074) Obstetrics and Gynecology (1231) Occupational and Environmental Health (1001) Oncology (3573) Ophthalmology (1036) Orthopedics (393) Otolaryngology (446) Pain Medicine (466) Palliative Medicine (139) Pathology (704) Pediatrics (1772) Pharmacology and Therapeutics (733) Primary Care Research (759) Psychiatry and Clinical Psychology (5832) Public and Global Health (9690) Radiology and Imaging (2387) Rehabilitation Medicine and Physical Therapy (1432) Respiratory Medicine (1239) Rheumatology (633) Sexual and Reproductive Health (766) Sports Medicine (576) Surgery (766) Toxicology (107) Transplantation (302) Urology (286)
## Related Clinical Research

- [Medical groups, Vaccine Integrity Project issue joint RSV, Covid-19, and influenza vaccine guidanc](https://medichelpline.com/clinical-feed/stat-news-0-doctors-groups-release-vaccination-guidelines-ahead-of-respiratory-illness.md)
- [Predictors of Seasonal Influenza and COVID-19 Vaccination Uptake in UK FluSurvey Participants (202](https://medichelpline.com/clinical-feed/medrxiv-0-factors-associated-with-vaccination-against-seasonal-influenza-and-sars-cov-2.md)
- [FDA approves Moderna’s mRNA flu vaccine mFLUSIVA for adults 50+: what clinicians should know](https://medichelpline.com/clinical-feed/medical-news-today-0-moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-available.md)
- [MMR vaccines: separating measles, mumps, rubella shots — myths and facts](https://medichelpline.com/clinical-feed/medical-news-today-0-should-the-measles-mumps-rubella-vaccines-be-separate-myths-vs-facts.md)
- [Ebola Preparedness: Addressing the Gap in Virus Species Research](https://medichelpline.com/clinical-feed/stat-news-9-opinion-we-prepared-for-ebola-but-not-this-ebola.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.